Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

Core Viewpoint - Neuronetics, Inc. has appointed Dan Reuvers as the new President and CEO, effective March 23, 2026, succeeding Keith Sullivan, who is retiring after five and a half years of leadership [1][2][3] Group 1: Leadership Transition - Dan Reuvers brings over 30 years of medical device experience and a strong track record of revenue growth and market expansion [1][2] - Reuvers previously served as CEO of Tactile Medical, where he increased revenue from $187 million to approximately $300 million [2] - Keith Sullivan is credited with transforming Neuronetics into a vertically integrated mental health platform and expanding its national clinic network [3] Group 2: Company Overview - Neuronetics focuses on improving the quality of life for patients with neurohealth disorders through its NeuroStar® Advanced Therapy [1][4] - The company operates Greenbrook TMS treatment centers across the U.S., providing NeuroStar Advanced Therapy for major depressive disorder (MDD) and other mental health conditions [5] - NeuroStar Advanced Therapy is the leading TMS treatment for MDD in adults, with over 8 million treatments delivered [5][6] Group 3: Future Outlook - Reuvers expressed commitment to expanding access to treatments for underserved patient populations suffering from depression [3] - The company aims to leverage its national care delivery network to drive profitable growth [3]